In a time of increasingly personalized healthcare, Elizabeth Philp has emerged as a significant figure of innovation, particularly in the fast-evolving field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a drive to make bespoke medication